Skip to main content
. 2019 Feb 11;12:373–384. doi: 10.2147/IDR.S186924

Table 3.

Comparative antibiotic resistance patterns in blaNDM-1-positive and blaNDM-1-negative Acinetobacter isolates

Antibiotics Disk content Total Acinetobacter isolates (64) blaNDM-1-positive Acinetobacter isolates (42) blaNDM-1-negative Acinetobacter isolates (22)
µg No (%) No (%) No (%)
Cefotaxime 30 64 (100) 42 (100) 22 (100)
Ceftazidime 30 64 (100) 42 (100) 22 (100)
Ceftriaxone 30 64 (100) 42 (100) 22 (100)
Cefepime 30 64 (100) 42 (100) 22 (100)
Trimethoprim/sulfamethoxazole 1.25/23.75 64 (100) 42 (100) 22 (100)
Piperacillin/tazobactam 100/10 62 (96.8) 42 (100) 20 (90.9)
Tetracycline 30 61 (95.3) 42 (100) 19 (86.3)
Aztreonam 30 60 (93.7) 42 (100) 18 (81.8)
Ciprofloxacin 5 58 (90.6) 42 (100) 16 (72.7)
Amikacin 30 58 (90.6) 42 (100) 16 (72.7)
Imipenem 10 54 (84.4) 42 (100) 12 (54.5)
Meropenem 10 54 (84.4) 42 (100) 12 (54.5)
Colistin 10 6 (9.3) 6 (14.3) 0

Abbreviation: blaNDM, New Delhi metallo-β-lactamase.